NASDAQ
Hua Medicine (Shanghai) Ltd. (HUMDF) has a price/sales ratio of 5.91x as of Friday, May 22, 2026. This represents a 89.03% decrease compared to its 12-month average of 53.86x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.